LINQ II Insertable Cardiac Monitor vs TOMTEC-ARENA

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
VS
by TOMTEC Imaging Systems GmbH

AI Verdict

Tool A, the Medtronic LINQ II, is an implantable cardiac monitor that uses AI for long-term, continuous heart rhythm monitoring and arrhythmia detection. Tool B, TOMTEC-ARENA, is an AI-powered software platform for advanced analysis, quantification, and reporting of existing medical images in cardiology and radiology. While both leverage AI in cardiology, they address different clinical needs: one focuses on physiological data collection and initial interpretation, and the other on comprehensive visual image analysis.

Choose LINQ II Insertable Cardiac Monitor if…

Choose the Medtronic LINQ II if your patients require long-term, continuous, and discreet monitoring for suspected or recurrent arrhythmias that may be difficult to capture with intermittent methods. This insertable cardiac monitor is ideal for extended diagnostic periods, offering AI-powered accuracy and remote management capabilities to streamline patient care and improve diagnostic yield.

View LINQ II Insertable Cardiac Monitor →

Choose TOMTEC-ARENA if…

Choose TOMTEC-ARENA if your institution needs a powerful, vendor-neutral software platform for advanced, AI-powered analysis and quantification of medical images across multiple modalities and specialties like cardiology and radiology. This solution is best suited for environments seeking to standardize and streamline diagnostic workflows with web-based access, comprehensive reporting, and seamless integration with existing PACS/EMR systems.

View TOMTEC-ARENA →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature LINQ II Insertable Cardiac Monitor TOMTEC-ARENA
Deployment Subcutaneous implant with remote monitoring via mobile app or home communicator. On-premise
FDA Status Cleared AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

TOMTEC-ARENA

TOMTEC-ARENA offers superior usability through comprehensive web-based diagnostic workflows, allowing access from various locations and devices, and has undergone a summative usability evaluation. While LINQ II simplifies patient interaction with mobile apps and home communicators, TOMTEC-ARENA's clinician-focused web-based platform and vendor-neutrality provide broader professional usability for image analysis.

Clinical Value

LINQ II Insertable Cardiac Monitor

LINQ II provides significant clinical value through long-term, continuous heart rhythm monitoring with AI algorithms that enhance accuracy, reduce false alerts by over 91%, and can predict risk thresholds for AF-related healthcare utilization. This direct, continuous patient data acquisition and AI-driven diagnostic improvement offer a profound impact on arrhythmia diagnosis and patient management. TOMTEC-ARENA offers advanced image analysis, but LINQ II's direct patient impact and proven reduction in false alerts give it an edge.

Pricing & Value

TOMTEC-ARENA

TOMTEC-ARENA explicitly offers flexible and scalable licensing options, including concurrent user licenses and 'small business' pricing models for private practices, suggesting a more adaptable and potentially cost-effective solution for a wider range of healthcare providers. In contrast, LINQ II's pricing is enterprise-focused and negotiated, with no public disclosure or free trial, implying less transparency and potentially higher entry barriers.

Enterprise Readiness

LINQ II Insertable Cardiac Monitor

LINQ II, backed by Medtronic, a global medical technology leader, explicitly states HIPAA compliance and FDA clearance, and has a proven track record with over a million patients worldwide. This demonstrates robust enterprise readiness, established trust, and adherence to critical regulatory standards. While TOMTEC-ARENA offers flexible deployment and integration, its HIPAA compliance and BAA details are not explicitly stated and require direct vendor contact, indicating less transparency for enterprise-level security requirements.

Innovation

LINQ II Insertable Cardiac Monitor

LINQ II demonstrates a higher degree of innovation by integrating AI into an implantable cardiac monitor for remote programming, long-term continuous monitoring, and significantly reducing false alerts by over 91%. This represents a pioneering application of AI in a device for direct patient data acquisition and improved diagnostic accuracy. TOMTEC-ARENA's multimodality, vendor-neutral AI for image analysis is also advanced, but LINQ II's innovation is more disruptive in the device space.

Support & Docs

LINQ II Insertable Cardiac Monitor

Medtronic, for LINQ II, offers extensive support including 24-hour technical support, patient service specialists available Monday-Friday, and a wealth of online resources such as clinician manuals and educational platforms like Medtronic Academy. While TOMTEC-ARENA mentions a 'premium TOMTEC service with an Up-to-Date maintenance contract', the breadth and depth of Medtronic's established global support infrastructure are more comprehensive.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature LINQ II Insertable Cardiac Monitor TOMTEC-ARENA
Name LINQ II Insertable Cardiac Monitor TOMTEC-ARENA
Company Medtronic TOMTEC Imaging Systems GmbH
Description The Medtronic LINQ II is an advanced, AI-powered insertable cardiac monitor providing long-term, continuous heart rhythm monitoring with remote programming and enhanced accuracy for diagnosing arrhythmias. TOMTEC-ARENA is an AI-powered, multimodality, vendor-neutral software for advanced medical image analysis, quantification, and reporting, primarily for cardiology and radiology, with web-based workflows.
Key Features AccuRhythmu2122 AI algorithms for enhanced accuracy, Remote programming capability, Up to 4.5 years of continuous monitoring, MRI compatibility (1.5 and 3.0T), MyCareLink Heartu2122 mobile app for data transmission, MyCareLink Relayu2122 home communicator option, Innovative PVC detection algorithm, Pediatric indication (ages 2+) AI-based measurement automation and data analytics, Multimodality and vendor-neutral imaging and analysis, Web-based diagnostic workflows (TOMTEC ZERO), Advanced quantification for various medical specialties, Structured reporting capabilities, DICOM connectivity and PACS/EMR integration, Automated archiving and data management, Support for 2D, 3D, and 4D image data

Videos

Demos, reviews, and walkthroughs featuring LINQ II Insertable Cardiac Monitor and TOMTEC-ARENA.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The Medtronic LINQ II is an insertable cardiac monitor designed for long-term, continuous heart rhythm monitoring and arrhythmia diagnosis, including a pediatric indication for ages 2 and up. TOMTEC-ARENA is a multimodality, vendor-neutral software for advanced medical image analysis, quantification, and reporting, primarily for cardiology and radiology.
The LINQ II uses AccuRhythmu2122 AI algorithms for enhanced accuracy in detecting arrhythmias and an innovative PVC detection algorithm, aiming to reduce false alerts while retaining true alerts. TOMTEC-ARENA leverages AI for measurement automation and data analytics in medical image analysis and quantification, which can independently perform many key echo measurements.
The LINQ II transmits data via the MyCareLink Heartu2122 mobile app or MyCareLink Relayu2122 home communicator, with remote programming capabilities. TOMTEC-ARENA offers automated archiving, data management, and web-based diagnostic workflows (TOMTEC ZERO) with DICOM connectivity and PACS/EMR integration.
AI Tool Finder
AI-powered search. Results may not be comprehensive.